Citations (93)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jianglong Xu, Jia Song, Menglin Xiao, Changsheng Wang, Qisong Zhang, Xiaoye Yuan & Shaohui Tian. (2021) RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1). Bioengineered 12:2, pages 11768-11781.
Read now
Read now
Tor-Christian Aase Johannessen & Joydeep Mukherjee. (2021) Phosphoglycerate mutase 1 (PGAM1) overexpression promotes radio- and chemoresistance in gliomas by activating the DNA damage response. Molecular & Cellular Oncology 8:2.
Read now
Read now
Ming Ji, Liyuan Wang, Ju Chen, Nina Xue, Chunyang Wang, Fangfang Lai, Rubing Wang, Shishan Yu, Jing Jin & Xiaoguang Chen. (2018) CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression. OncoTargets and Therapy 11, pages 3671-3684.
Read now
Read now
R. J. Head, M. F. Fay, L. Cosgrove, K. Y. C. Fung, D. Rundle-Thiele & J. H. Martin. (2017) Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma. Cancer Biology & Therapy 18:12, pages 917-926.
Read now
Read now
Tao Song, Hui Li, Zhiliang Tian, Chaojiu Xu, Jingfang Liu & Yong Guo. (2015) Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells. OncoTargets and Therapy 8, pages 2199-2208.
Read now
Read now
Barbara Banelli, Elisa Carra, Federica Barbieri, Roberto Würth, Federica Parodi, Alessandra Pattarozzi, Roberta Carosio, Alessandra Forlani, Giorgio Allemanni, Daniela Marubbi, Tullio Florio, Antonio Daga & Massimo Romani. (2015) The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Cell Cycle 14:21, pages 3418-3429.
Read now
Read now
Articles from other publishers (87)
Laurent Turchi, Nathalie Sakakini, Gaelle Saviane, Béatrice Polo, Mirca Saras Saurty-Seerunghen, Mathieu Gabut, Corine Auge Gouillou, Vincent Guerlais, Claude Pasquier, Marie Luce Vignais, Fabien Almairac, Hervé Chneiweiss, Marie-Pierre Junier, Fanny Burel-Vandenbos & Thierry Virolle. (2023) CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 15:20, pages 5038.
Crossref
Crossref
Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, John Wright, Joel Morris, James H. Doroshow & Beverly A. Teicher. (2023) Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs. Cancer Research Communications 3:8, pages 1648-1661.
Crossref
Crossref
Vanishree Rao, Gautam Kumar, R.J.A. Vibhavari, Krishnadas Nandakumar, Nanasaheb D. Thorat, Mallikarjuna Rao Chamallamudi & Nitesh Kumar. (2023) Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond
O-6-Methylguanine-DNA Methyltransferase. CNS & Neurological Disorders - Drug Targets 22:6, pages 817-831.
Crossref
Crossref
Jen-Tsung Yang, I-Neng Lee, Cheng Huang, Hsiu-Chen Huang, Yu-Ping Wu, Zhi-Yong Chong & Jui-Chieh Chen. (2023) ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. International Journal of Molecular Sciences 24:9, pages 7703.
Crossref
Crossref
Wajd N. Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, Sunita Shankar, Morgan Oneka, Ziad Fehmi, Roel GW Verhaak, Hoon Kim, Drew Pratt, Sandra Camelo-Piragua, Corey Speers, Daniel R Wahl, Todd Hollon, Oren Sagher, Jason A Heth, Karin M. Muraszko, Theodore S. Lawrence, Ana C de Carvalho, Tom Mikkelsen, Arvind Rao & Alnawaz Rehemtulla. (2023) Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma. Neoplasia 36, pages 100872.
Crossref
Crossref
David Gibson, Akshay Ravi, Eduardo Rodriguez, Susan Chang, Nancy Oberheim Bush, Jennie Taylor, Jennifer Clarke, David Solomon, Aaron Scheffler, John Witte, Hannah Lambing, Hideho Okada, Mitchel Berger, Farid Chehab & Nicholas A Butowski. (2023)
Quantitative analysis of
MGMT
promoter methylation in glioblastoma suggests nonlinear prognostic effect
. Neuro-Oncology Advances 5:1.
Crossref
Crossref
Annibale Alessandro Puca, Valentina Lopardo, Francesco Montella, Paola Di Pietro, Daniela Cesselli, Irene Giulia Rolle, Michela Bulfoni, Veronica Di Sarno, Giorgio Iaconetta, Pietro Campiglia, Carmine Vecchione, Antonio Paolo Beltrami & Elena Ciaglia. (2022) The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy Efficacy. Cells 11:2, pages 294.
Crossref
Crossref
JÉSSICA S. SOLDATELLI, IURI M. DE OLIVEIRA, MAXIMILIANO C. KNEUBIL & JOÃO ANTONIO P. HENRIQUES. (2022) Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system. Anais da Academia Brasileira de Ciências 94:3.
Crossref
Crossref
Isra Saif Eldin Eisa Sati & Ishwar Parhar. (2021) MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma. International Journal of Molecular Sciences 22:24, pages 13550.
Crossref
Crossref
Lara H. El Touny, Curtis Hose, John Connelly, Erik Harris, Anne Monks, Angie B. Dull, Deborah F. Wilsker, Melinda G. Hollingshead, Michelle Gottholm-Ahalt, Sergio Y. Alcoser, Michael E. Mullendore, Ralph E. Parchment, James H. Doroshow, Beverly A. Teicher & Annamaria Rapisarda. (2021) ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide. Oncotarget 12:21, pages 2114-2130.
Crossref
Crossref
Gustavo Ulises Martinez-Ruiz, Abigail Morales-Sanchez & Angel Francisco Pacheco-Hernandez. (2021) Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells. Stem Cell Reviews and Reports 17:5, pages 1590-1606.
Crossref
Crossref
Andréa A. Lebel, Michée V. Kisembo, Marie-France N. Soucy, Mathieu P.A. Hébert, Pier Jr Morin & Luc H. Boudreau. (2021) Molecular characterization of the anticancer properties associated with bee venom and its components in glioblastoma multiforme. Chemico-Biological Interactions 347, pages 109622.
Crossref
Crossref
Silvia A. Teixeira, Mariano S. Viapiano, Augusto F. Andrade, Mohan S. Nandhu, Julia A. Pezuk, Lucas T. Bidinotto, Veridiana K. Suazo, Luciano Neder, Carlos G. Carlotti, Aline P. Becker, Luiz Gonzaga Tone & Carlos A. Scrideli. (2021) The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth. Molecular Neurobiology 58:9, pages 4520-4534.
Crossref
Crossref
Vanishree Rao, Sri Pragnya Cheruku, Suman Manandhar, R. J. A. Vibhavari, Krishnadas Nandakumar, C. Mallikarjuna Rao, V. Ravichandiran & Nitesh Kumar. (2021) Restoring chemo-sensitivity to temozolomide via targeted inhibition of poly (ADP-ribose) polymerase-1 by naringin in glioblastoma. Chemical Papers 75:9, pages 4861-4871.
Crossref
Crossref
Yan Lu, Meng Tian, Jiongbo Liu & Kuanhong Wang. (2021) LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR‐126‐5p and activating Wnt/β‐catenin signaling. Journal of Biochemical and Molecular Toxicology 35:9.
Crossref
Crossref
Alexandra Y. Tsidulko, Oleg B. Shevelev, Anna S. Khotskina, Mariia A. Kolpakova, Anastasia V. Suhovskih, Galina M. Kazanskaya, Alexander M. Volkov, Svetlana V. Aidagulova, Evgenii L. Zavyalov & Elvira V. Grigorieva. (2021) Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model. Frontiers in Oncology 11.
Crossref
Crossref
Vera Miranda-Gonçalves, Céline S. Gonçalves, Sara Granja, Joana Vieira de Castro, Rui M. Reis, Bruno M. Costa & Fátima Baltazar. (2021) MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. Cancers 13:14, pages 3468.
Crossref
Crossref
Madineh Mazarei, Pooria Mohammadi Arvejeh, M. R. Mozafari, Pegah Khosravian & Sorayya Ghasemi. (2021) Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation. Nanomaterials 11:7, pages 1704.
Crossref
Crossref
Xiang Ye, Xiaochen Liu, Min Gao, Li Gong, Fei Tian, Yangli Shen, Huili Hu, Gongping Sun, Yongxin Zou & Yaoqin Gong. (2021) CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription. Frontiers in Oncology 11.
Crossref
Crossref
Yingbo Huang, Alexander Ling, Siddhika Pareek & R Stephanie Huang. (2021) Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type. Translational Research 230, pages 98-110.
Crossref
Crossref
Gustavo Ulises Martinez-Ruiz & Abigail Morales-Sanchez. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
39
57
.
Clarissa Ribeiro Reily Rocha, Alexandre Reily Rocha, Matheus Molina Silva, Luciana Rodrigues Gomes, Marcela Teatin Latancia, Marina Andrade-Tomaz, Izadora de Souza, Linda Karolynne Seregni Monteiro & Carlos Frederico Martins Menck. (2020) Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries. Cells 9:12, pages 2573.
Crossref
Crossref
Nagore I. Marín-Ramos, Marta Pérez-Hernández, Anson Tam, Stephen D. Swenson, Hee-Yeon Cho, Thu Zan Thein, Florence M. Hofman & Thomas C. Chen. (2020) Inhibition of motility by NEO100 through the calpain-1/RhoA pathway. Journal of Neurosurgery 133:4, pages 1020-1031.
Crossref
Crossref
Ana Gabriela Silva, Viviane Aline O. Silva, Renato J. S. Oliveira, Allisson Rodrigues de Rezende, Rafael César Russo Chagas, Lúcia Pinheiro Santos Pimenta, Wanderson Romão, Hélio Batista Santos, Ralph Gruppi Thomé, Rui Manuel Reis & Rosy Iara Maciel de Azambuja Ribeiro. (2019) Matteucinol, isolated from Miconia chamissois, induces apoptosis in human glioblastoma lines via the intrinsic pathway and inhibits angiogenesis and tumor growth in vivo. Investigational New Drugs 38:4, pages 1044-1055.
Crossref
Crossref
Agnieszka Gizak, Przemysław Duda, Ewa Pielka, James A. McCubrey & Dariusz Rakus. (2020) GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:7, pages 118696.
Crossref
Crossref
Guangyong Chen, Zhuo Chen & Hang Zhao. (2020) MicroRNA‐155‐3p promotes glioma progression and temozolomide resistance by targeting Six1. Journal of Cellular and Molecular Medicine 24:9, pages 5363-5374.
Crossref
Crossref
Shiqi Kong, Yingxiao Cao, Xin Li, Zhenzhong Li, Yuling Xin & Yan Meng. (2020) MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway. Journal of Cellular and Molecular Medicine 24:8, pages 4677-4686.
Crossref
Crossref
Zhicheng Yao, Shida Yang, Hongyou Zhao, Huike Yang & Xin Jiang. (2019) RETRACTED ARTICLE: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction. Cancer Gene Therapy 27:3-4, pages 226-234.
Crossref
Crossref
Hang Cao, Xuejun Li, Feiyifan Wang, Yueqi Zhang, Yi Xiong & Qi Yang. (2020) Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems. Current Medicinal Chemistry 27:4, pages 599-629.
Crossref
Crossref
Shengyu Zhao, Ru-Bing Wang, Jie Bai, Xiaoqing Fan, Minwan Hu, Baolian Wang, Jinping Hu & Yan Li. (2020) Simultaneous determination of a promising anti-brain tumor agent CAT3 and its two major metabolites in mouse plasma and brain by a LC-MS/MS method. Journal of Pharmaceutical and Biomedical Analysis 181, pages 113106.
Crossref
Crossref
Rencui Quan, Huaqing ZhangZihuang Li & Xianming Li. (2020) Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide. Medicine 99:2, pages e18591.
Crossref
Crossref
Bor-Chyuan Su & Jyh-Yih Chen. (2019) Pharmacological inhibition of p38 potentiates antimicrobial peptide TP4-induced cell death in glioblastoma cells. Molecular and Cellular Biochemistry 464:1-2, pages 1-9.
Crossref
Crossref
Shijie Ma, Tao Fu, Shuyang Zhao & Ming Gao. (2019) MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2. European Journal of Pharmacology 852, pages 42-50.
Crossref
Crossref
Nisha Kumari, Nishant Thakur, Hye Rim Cho & Seung Hong Choi. (2019) Assessment of Early Therapeutic Response to Nitroxoline in Temozolomide-Resistant Glioblastoma by Amide Proton Transfer Imaging: A Preliminary Comparative Study with Diffusion-weighted Imaging. Scientific Reports 9:1.
Crossref
Crossref
Daisuke Ogawa, Khairul Ansari, Michal Nowicki, Elżbieta Salińska, Agnieszka Bronisz & Jakub Godlewski. (2019) MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy. Non-Coding RNA 5:1, pages 25.
Crossref
Crossref
Hee-Yeon Cho, Thu Zan Thein, Weijun Wang, Stephen D. Swenson, Rochelle A. Fayngor, Mengting Ou, Nagore I. Marín-Ramos, Axel H. Schönthal, Florence M. Hofman & Thomas C. Chen. (2019) The Rolipram–Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor Pathway. Molecular Cancer Therapeutics 18:3, pages 517-530.
Crossref
Crossref
Jessian L. Munoz, Nykia D. Walker, Satvik Mareedu, Sri Harika Pamarthi, Garima Sinha, Steven J. Greco & Pranela Rameshwar. (2019) Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D. Frontiers in Pharmacology 10.
Crossref
Crossref
Yixing Gao, Bao Liu, Lan Feng, Binda Sun, Shu He, Yidong Yang, Gang Wu, Guoji E, Chang Liu, Yuqi Gao, Erlong Zhang & Bo Zhu. (2019) Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma. Frontiers in Oncology 9.
Crossref
Crossref
Tae Hwang, Dong Kim, Da Kim, Tae Jang, Gun‑Hwa Kim, Minho Moon, Kyung Yoon, Dae Choi, Jae Park & Jwa‑Jin Kim. (2019) Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy. International Journal of Molecular Medicine.
Crossref
Crossref
Ravi P. Cholia, Monisha Dhiman, Raj Kumar & Anil K. Mantha. (2018) Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes. Metabolic Brain Disease 33:4, pages 1307-1326.
Crossref
Crossref
Nagore I. Marín-Ramos, Thu Zan Thein, Hee-Yeon Cho, Stephen D. Swenson, Weijun Wang, Axel H. Schönthal, Thomas C. Chen & Florence M. Hofman. (2018) NEO212 Inhibits Migration and Invasion of Glioma Stem Cells. Molecular Cancer Therapeutics 17:3, pages 625-637.
Crossref
Crossref
Quanye Sun, Chunying Pei, Qiuyuan Li, Tianxiu Dong, Yucui Dong, Wenjing Xing, Peng Zhou, Yujiao Gong, Ziqi Zhen, Yifan Gao, Yun Xiao, Jun Su & Huan Ren. (2018) Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma. Biochemical and Biophysical Research Communications 496:4, pages 1040-1046.
Crossref
Crossref
D N Debruyne, L Turchi, F Burel-Vandenbos, M Fareh, F Almairac, V Virolle, D Figarella-Branger, N Baeza-Kallee, P Lagadec, V kubiniek, P Paquis, D Fontaine, M-P Junier, H Chneiweiss & T Virolle. (2017) DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression. Oncogene 37:2, pages 241-254.
Crossref
Crossref
Zhongling Zhu, Shuangshuang Du, Yibo Du, Jing Ren, Guoguang Ying & Zhao Yan. (2018) Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. Journal of Neurochemistry 144:1, pages 93-104.
Crossref
Crossref
Ru-Bing Wang, Hai-Ning Lv, Shan-Shan Zhu, Xiao-Dong Ren, Song Xu, Shuang-Gang Ma, Yun-Bao Liu, Jing Qu & Shi-Shan Yu. (2018) A novel and practical synthesis of CAT3: a phenanthroindolizidine alkaloid with potential in treating glioblastoma. RSC Advances 8:51, pages 29301-29308.
Crossref
Crossref
Maria J. Ramalho, Manuel A.N. Coelho & Maria C. Pereira. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
687
722
.
Jin Han Nam, Hyun‐Ji Cho, Hyejin Kang, Ju‐Young Lee, Mira Jung, Young‐Chae Chang, Keetae Kim & Hyang‐Sook Hoe. (2017) A Mercaptoacetamide‐Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling. Journal of Cellular Biochemistry 118:12, pages 4672-4685.
Crossref
Crossref
Jason Choi, Alexandre Moquin, Enzo Bomal, Li Na, Dusica Maysinger & Ashok Kakkar. (2017) Telodendrimers for Physical Encapsulation and Covalent Linking of Individual or Combined Therapeutics. Molecular Pharmaceutics 14:8, pages 2607-2615.
Crossref
Crossref
Deborah T. Blumenthal, Thierry Gorlia, Mark R. Gilbert, Michelle M. Kim, L. Burt Nabors, Warren P. Mason, Monika E. Hegi, Peixin Zhang, Vassilis Golfinopoulos, James R. Perry, Do Hyun Nam, Sara C. Erridge, Benjamin W. Corn, René O Mirimanoff, Paul D. Brown, Brigitta G. Baumert, Minesh P. Mehta, Martin J. van den Bent, David A. Reardon, Michael Weller & Roger Stupp. (2017) Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology 19:8, pages 1119-1126.
Crossref
Crossref
Kiran K. Velpula, Maheedhara R. Guda, Kamlesh Sahu, Jack Tuszynski, Swapna Asuthkar, Sarah E. Bach, Justin D. Lathia & Andrew J. Tsung. (2017) Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma. Oncotarget 8:22, pages 35639-35655.
Crossref
Crossref
Laura Annovazzi, Marta Mellai & Davide Schiffer. (2017) Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma. Cancers 9:6, pages 57.
Crossref
Crossref
Kaishu Li, Leping Ouyang, Mingliang He, Ming Luo, Wangqing Cai, Yalin Tu, Rongbiao Pi & Anmin Liu. (2017) IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway. Oncotarget 8:17, pages 28865-28879.
Crossref
Crossref
Megan M. Marlow, Sumedh S. Shah, Eduardo A. Véliz, Michael E. Ivan & Regina M. Graham. (2016) Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives. Journal of Natural Medicines 71:1, pages 16-26.
Crossref
Crossref
Guan Jiang, Ronghua Li, Jianqin Tang, Yafeng Ma, Xiaoyang Hou, Chunsheng Yang, Wenwen Guo, Yong Xin & Yanqun Liu. (2016) Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells. Oncology Reports.
Crossref
Crossref
Kelly L. Mooney, Winward Choy, Sabrin Sidhu, Panayiotis Pelargos, Timothy T. Bui, Brittany Voth, Natalie Barnette & Isaac Yang. (2016) The role of CD44 in glioblastoma multiforme. Journal of Clinical Neuroscience 34, pages 1-5.
Crossref
Crossref
Tian Tian, Ma Mingyi, Xia Qiu & Yang Qiu. (2016) MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Oncotarget 7:48, pages 79584-79595.
Crossref
Crossref
Ju Chen, Haining Lv, Jinping Hu, Ming Ji, Nina Xue, Chao Li, Shuanggang Ma, Qin Zhou, Bin Lin, Yan Li, Shishan Yu & Xiaoguang Chen. (2016) CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway. Cancer Letters 381:2, pages 391-403.
Crossref
Crossref
Jun Yang, Yan Li, Tianlu Zhang & Xin Zhang. (2016) Development of bioactive materials for glioblastoma therapy. Bioactive Materials 1:1, pages 29-38.
Crossref
Crossref
Clarissa Ribeiro Reily Rocha, Gustavo Satoru Kajitani, Annabel Quinet, Rodrigo Soares Fortunato & Carlos Frederico Martins Menck. (2016) NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Oncotarget 7:30, pages 48081-48092.
Crossref
Crossref
Marina Radoul, Myriam M. Chaumeil, Pia Eriksson, Alan S. Wang, Joanna J. Phillips & Sabrina M. Ronen. (2016) MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. Molecular Cancer Therapeutics 15:5, pages 1113-1122.
Crossref
Crossref
Fengbo Yu, Guihong Li, Junxia Gao, Yuxue Sun, Pengfei Liu, Haijun Gao, Peiwen Li, Ting Lei, Yong Chen, Ye Cheng, Xiao Zhai, Arash. J. Sayari, Haiyan Huang & Qingchun Mu. (2016) SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance. Cell Proliferation 49:2, pages 195-206.
Crossref
Crossref
Shannon P. Fortin Ensign, Alison Roos, Ian T. Mathews, Harshil D. Dhruv, Serdar Tuncali, Jann N. Sarkaria, Marc H. Symons, Joseph C. Loftus, Michael E. Berens & Nhan L. Tran. (2016) SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide. Molecular Cancer Research 14:3, pages 302-312.
Crossref
Crossref
Niyati Jhaveri, Fabienne Agasse, Don Armstrong, Lilei Peng, Deborah Commins, Weijun Wang, Rachel Rosenstein-Sisson, Vijaya Pooja Vaikari, Shayane V. Santiago, Tiago Santos, Ligang Chen, Axel H. Schönthal, Thomas C. Chen & Florence M. Hofman. (2016) A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Cancer Letters 371:2, pages 240-250.
Crossref
Crossref
HAO LI, YAODONG LIU, YUMIN JIAO, ANCHEN GUO, XIAOXUE XU, XIANJUN QU, SHUO WANG, JIZONG ZHAO, YE LI & YONG CAO. (2016) Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation. Oncology Reports 35:1, pages 343-351.
Crossref
Crossref
Hátylas Azevedo & Carlos Alberto Moreira-Filho. (2015) Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma. Scientific Reports 5:1.
Crossref
Crossref
Ahmed Idbaih, Alberto Duran-peña & Agusti Alentorn. (2015) Thérapie ciblée des glioblastomes : bilan et perspectives. Bulletin de l'Académie Nationale de Médecine 199:8-9, pages 1323-1329.
Crossref
Crossref
C Maris, N D'Haene, A-L Trépant, M Le Mercier, S Sauvage, J Allard, S Rorive, P Demetter, C Decaestecker & I Salmon. (2015) IGF-IR: a new prognostic biomarker for human glioblastoma. British Journal of Cancer 113:5, pages 729-737.
Crossref
Crossref
Tian Tian, Aimin Li, Hong Lu, Ran Luo, Mingzhi Zhang & Zhaoming Li. (2015) TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells. Biochemical and Biophysical Research Communications 463:4, pages 638-643.
Crossref
Crossref
HIROSHI KAWAJI, TSUTOMU TOKUYAMA, TOMOHIRO YAMASAKI, SHINJI AMANO, NAOTO SAKAI & HIROKI NAMBA. (2015) Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas. Molecular and Clinical Oncology 3:4, pages 909-913.
Crossref
Crossref
Alan Siu, Olga Volotskova, Xiaoqian Cheng, Siri S. Khalsa, Ka Bian, Ferid Murad, Michael Keidar & Jonathan H. Sherman. (2015) Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma. PLOS ONE 10:6, pages e0126313.
Crossref
Crossref
LAURA ANNOVAZZI, VALENTINA CALDERA, MARTA MELLAI, CHIARA RIGANTI, LUIGI BATTAGLIA, DANIELA CHIRIO, ANTONIO MELCARNE & DAVIDE SCHIFFER. (2015) The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment. International Journal of Oncology 46:6, pages 2299-2308.
Crossref
Crossref
Leina Ma, Jia Liu, Xinling Zhang, Jieqiong Qi, Wengong Yu & Yuchao Gu. (2015) p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ. Medical Oncology 32:3.
Crossref
Crossref
Gagandeep Kaur, Ravi P. Cholia, Anil K. Mantha & Raj Kumar. (2014) DNA Repair and Redox Activities and Inhibitors of Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor 1 (APE1/Ref-1): A Comparative Analysis and Their Scope and Limitations toward Anticancer Drug Development. Journal of Medicinal Chemistry 57:24, pages 10241-10256.
Crossref
Crossref
Jeffrey V. Brower, Paul A. Clark, Will Lyon & John S. Kuo. (2014) MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells. Neurochemistry International 77, pages 68-77.
Crossref
Crossref
C R R Rocha, C C M Garcia, D B Vieira, A Quinet, L C de Andrade-Lima, V Munford, J E Belizário & C F M Menck. (2014) Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death & Disease 5:10, pages e1505-e1505.
Crossref
Crossref
Chia-Leng Liao, Chien-Min Chen, Yan-Zin Chang, Guang-Yaw Liu, Hui-Chih Hung, Tung-Ying Hsieh & Chih-Li Lin. (2014)
Pine (
Pinus morrisonicola
Hayata) Needle Extracts Sensitize GBM8901 Human Glioblastoma Cells to Temozolomide by Downregulating Autophagy and
O
6
-Methylguanine-DNA Methyltransferase Expression
. Journal of Agricultural and Food Chemistry 62:43, pages 10458-10467.
Crossref
Crossref
Anjing Gong, Na Ge, Weicheng Yao, Luxiang Lu & Hui Liang. (2014) RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Cancer Chemotherapy and Pharmacology 74:3, pages 531-538.
Crossref
Crossref
Hee-Yeon Cho, Weijun Wang, Niyati Jhaveri, David Jungpa Lee, Natasha Sharma, Louis Dubeau, Axel H. Schönthal, Florence M. Hofman & Thomas C. Chen. (2014) NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas. Molecular Cancer Therapeutics 13:8, pages 2004-2017.
Crossref
Crossref
Xing-Qi Li, Zhi-Gang Ouyang, Sheng-Hua Zhang, Hong Liu, Yue Shang, Yi Li & Yong-Su Zhen. (2014) Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction. Journal of Neuro-Oncology 119:1, pages 91-100.
Crossref
Crossref
Christina Perry, Devika Agarwal, Tarek M.A. Abdel-Fatah, Anbarasu Lourdusamy, Richard Grundy, Dorothee T. Auer, David Walker, Ravi Lakhani, Ian S. Scott, Stephen Chan, Graham Ball & Srinivasan Madhusudan. (2014) Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era. Oncotarget 5:14, pages 5764-5781.
Crossref
Crossref
Matthias Duebgen, Jordi Martinez-Quintanilla, Kaoru Tamura, Shawn Hingtgen, Navid Redjal, Hiroaki Wakimoto & Khalid Shah. (2014) Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy. JNCI: Journal of the National Cancer Institute 106:6.
Crossref
Crossref
J L Munoz, V Rodriguez-Cruz, S J Greco, S H Ramkissoon, K L Ligon & P Rameshwar. (2014) Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death & Disease 5:3, pages e1145-e1145.
Crossref
Crossref
Koji SagiyamaTomoyuki Mashimo, Osamu TogaoVamsidhara VemireddyKimmo J. HatanpaaElizabeth A. MaherBruce E. Mickey, Edward PanA. Dean Sherry, Robert M. BachooMasaya Takahashi. (2014) In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proceedings of the National Academy of Sciences 111:12, pages 4542-4547.
Crossref
Crossref
Tamador Elsir, Per‐Henrik Edqvist, Joseph Carlson, Dan Ribom, Michael Bergqvist, Simon Ekman, Svetlana N. Popova, Irina Alafuzoff, Fredrik Ponten, Monica Nistér & Anja Smits. (2013) A study of embryonic stem cell‐related proteins in human astrocytomas: Identification of Nanog as a predictor of survival. International Journal of Cancer 134:5, pages 1123-1131.
Crossref
Crossref
Prudence Donovan, Kathleen Cato, Roxane Legaie, Rumal Jayalath, Gemma Olsson, Bruce Hall, Sarah Olson, Samuel Boros, Brent A. Reynolds & Angus Harding. (2014) Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors. Mol. BioSyst. 10:4, pages 741-758.
Crossref
Crossref
Linda Sooman, Simon Ekman, Claes Andersson, Hanna Göransson Kultima, Anders Isaksson, Fredrik Johansson, Michael Bergqvist, Erik Blomquist, Johan Lennartsson & Joachim Gullbo. (2013) Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines. Cancer Chemotherapy and Pharmacology 72:2, pages 329-340.
Crossref
Crossref
Yu-Ling Lin, Wen-Lin Lai, Horng-jyh Harn, Pei-Hsiu Hung, Ming-Chang Hsieh, Kai-Fu Chang, Xiao-Fan Huang, Kuang-Wen Liao, Ming-Shih Lee & Nu-Man Tsai. (2013)
The Methanol Extract of
Angelica sinensis
Induces Cell Apoptosis and Suppresses Tumor Growth in Human Malignant Brain Tumors
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Crossref